Negative regulation of human U6 snRNA promoter by p38 kinase through Oct-1

Gene

Volumn 497, Issue 2, 2012, Pages 200-207

  Lin, Bor Ruei ^a   Natarajan, Ven ^a  

^a SAIC FREDERICK INC   (United States)

Author keywords

MAPK; Oct 1; P38 kinase; SB202190; U6 promoter

Indexed keywords

HYDROGEN PEROXIDE; OCTAMER TRANSCRIPTION FACTOR 1; PHORBOL 13 ACETATE 12 MYRISTATE; SMALL NUCLEAR RNA; SMALL NUCLEAR RNA U6; SYNAPTOPHYSIN; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; DOWN REGULATION; GEL MOBILITY SHIFT ASSAY; GENE ACTIVATION; GENE CONTROL; GENE EXPRESSION; GENE SEQUENCE; GENETIC TRANSCRIPTION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; LEUKEMIA CELL LINE; OXIDATIVE STRESS; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; PROTEIN EXPRESSION;

DNA-BINDING PROTEINS; DOWN-REGULATION; HUMANS; IMIDAZOLES; JURKAT CELLS; MUTATION; OCTAMER TRANSCRIPTION FACTOR-1; OXIDATIVE STRESS; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PROMOTER REGIONS, GENETIC; PYRIDINES; REGULATORY SEQUENCES, NUCLEIC ACID; RNA, SMALL NUCLEAR; TRANSCRIPTION, GENETIC; TUMOR CELLS, CULTURED;

EID: 84858294719     PISSN: 03781119     EISSN: 18790038     Source Type: Journal    
DOI: 10.1016/j.gene.2012.01.041     Document Type: Article

References (60)

1. Advani S.J., Durand L.O., Weichselbaum R.R., Roizman B. Oct-1 is posttranslationally modified and exhibits reduced capacity to bind cognate sites at late times after infection with herpes simplex virus 1. J. Virol. 2003, 77:11927-11932.
2. Ashwell J.D. The many paths to p38 mitogen-activated protein kinase activation in the immune system. Nat. Rev. Immunol. 2006, 6:532-540.
3. Bardwell L. Mechanisms of MAPK signalling specificity. Biochem. Soc. Trans. 2006, 34:837-841.
4. Barsyte-Lovejoy D., Galanis A., Sharrocks A.D. Specificity determinants in MAPK signaling to transcription factors. J. Biol. Chem. 2002, 277:9896-9903.
5. Boyd D.C., Greger I.H., Murphy S. In vivo footprinting studies suggest a role for chromatin in transcription of the human 7SK gene. Gene 2000, 247:33-44.
6. Bulavin D.V., et al. Initiation of a G2/M checkpoint after ultraviolet radiation requires p38 kinase. Nature 2001, 411:102-107.
7. Carbon P., Murgo S., Ebel J.P., Krol A., Tebb G., Mattaj L.W. A common octamer motif binding protein is involved in the transcription of U6 snRNA by RNA polymerase III and U2 snRNA by RNA polymerase II. Cell 1987, 51:71-79.
8. Davies S.P., Reddy H., Caivano M., Cohen P. Specificity and mechanism of action of some commonly used protein kinase inhibitors. Biochem. J. 2000, 351:95-105.
9. Dekker N., Cox M., Boelens R., Verrijzer C.P., van der Vliet P.C., Kaptein R. Solution structure of the POU-specific DNA-binding domain of Oct-1. Nature 1993, 362:852-855.
10. Domitrovich A.M., Kunkel G.R. Multiple, dispersed human U6 small nuclear RNA genes with varied transcriptional efficiencies. Nucleic Acids Res. 2003, 31:2344-2352.
11. Grenfell S.J., Latchman D.S., Thomas N.S. Oct-1 and Oct-2 DNA-binding site specificity is regulated in vitro by different kinases. Biochem. J. 1996, 315(Pt 3):889-893.
12. 2. Role in cell survival following oxidant injury. J. Biol. Chem. 1996, 271:4138-4142.
13. Huang Z., Traugh J.A., Bishop J.M. Negative control of the Myc protein by the stress-responsive kinase Pak2. Mol. Cell. Biol. 2004, 24:1582-1594.
14. Hunter T., Karin M. The regulation of transcription by phosphorylation. Cell 1992, 70:375-387.
15. Jawdekar G.W., Henry R.W. Transcriptional regulation of human small nuclear RNA genes. Biochim. Biophys. Acta 2008, 1779:295-305.
16. Johnson G.L., Lapadat R. Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases. Science 2002, 298:1911-1912.
17. Kang J., et al. A general mechanism for transcription regulation by Oct1 and Oct4 in response to genotoxic and oxidative stress. Genes Dev. 2009, 23:208-222.
18. Klemm J.D., Rould M.A., Aurora R., Herr W., Pabo C.O. Crystal structure of the Oct-1 POU domain bound to an octamer site: DNA recognition with tethered DNA-binding modules. Cell 1994, 77:21-32.
19. Krasilnikov M., Ivanov V.N., Dong J., Ronai Z. ERK and PI3K negatively regulate STAT-transcriptional activities in human melanoma cells: implications towards sensitization to apoptosis. Oncogene 2003, 22:4092-4101.
20. Kunkel G.R., Pederson T. Upstream elements required for efficient transcription of a human U6 RNA gene resemble those of U1 and U2 genes even though a different polymerase is used. Genes Dev. 1988, 2:196-204.
21. Kunkel G.R., Maser R.L., Calvet J.P., Pederson T. U6 small nuclear RNA is transcribed by RNA polymerase III. Proc. Natl. Acad. Sci. U. S. A. 1986, 83:8575-8579.
22. Kyriakis J.M., Avruch J. Mammalian mitogen-activated protein kinase signal transduction pathways activated by stress and inflammation. Physiol. Rev. 2001, 81:807-869.
23. Lee J.C., et al. A protein kinase involved in the regulation of inflammatory cytokine biosynthesis. Nature 1994, 372:739-746.
24. Lee J.C., Kumar S., Griswold D.E., Underwood D.C., Votta B.J., Adams J.L. Inhibition of p38 MAP kinase as a therapeutic strategy. Immunopharmacology 2000, 47:185-201.
25. Lee L., et al. Expression of the Oct-1 transcription factor and characterization of its interactions with the Bob1 coactivator. Biochemistry 2001, 40:6580-6588.
26. Lobo S.M., Hernandez N. A 7 bp mutation converts a human RNA polymerase II snRNA promoter into an RNA polymerase III promoter. Cell 1989, 58:55-67.
27. Mattaj I.W., Dathan N.A., Parry H.D., Carbon P., Krol A. Changing the RNA polymerase specificity of U snRNA gene promoters. Cell 1988, 55:435-442.
28. Mauro A., et al. PKCa-mediated ERK, JNK and p38 activation regulates the myogenic program in human rhabdomyosarcoma cells. J. Cell Sci. 2002, 115:3587-3599.
29. Meighan-Mantha R.L., et al. Ionizing radiation stimulates octamer factor DNA binding activity in human carcinoma cells. Mol. Cell. Biochem. 1999, 199:209-215.
30. Mittal V., Cleary M.A., Herr W., Hernandez N. The Oct-1 POU-specific domain can stimulate small nuclear RNA gene transcription by stabilizing the basal transcription complex SNAPc. Mol. Cell. Biol. 1996, 16:1955-1965.
31. Myslinski E., Gerard M.A., Krol A., Carbon P. A genome scale location analysis of human Staf/ZNF143-binding sites suggests a widespread role for human Staf/ZNF143 in mammalian promoters. J. Biol. Chem. 2006, 281:39953-39962.
32. Ono K., Han J. The p38 signal transduction pathway: activation and function. Cell. Signal. 2000, 12:1-13.
33. Pedraza-Alva G., et al. Activation of p38 MAP kinase by DNA double-strand breaks in V(D)J recombination induces a G2/M cell cycle checkpoint. EMBO J. 2006, 25:763-773.
34. Pevzner V., Kraft R., Kostka S., Lipp M. Phosphorylation of Oct-2 at sites located in the POU domain induces differential down-regulation of Oct-2 DNA-binding ability. Biochem. J. 2000, 347(Pt 1):29-35.
35. Phillips K., Luisi B. The virtuoso of versatility: POU proteins that flex to fit. J. Mol. Biol. 2000, 302:1023-1039.
36. Roberts S.B., Segil N., Heintz N. Differential phosphorylation of the transcription factor Oct1 during the cell cycle. Science 1991, 253:1022-1026.
37. Schild-Poulter C., et al. The binding of Ku antigen to homeodomain proteins promotes their phosphorylation by DNA-dependent protein kinase. J. Biol. Chem. 2001, 276:16848-16856.
38. Schild-Poulter C., Shih A., Yarymowich N.C., Hache R.J. Down-regulation of histone H2B by DNA-dependent protein kinase in response to DNA damage through modulation of octamer transcription factor 1. Cancer Res. 2003, 63:7197-7205.
39. Schild-Poulter C., et al. DNA-PK phosphorylation sites on Oct-1 promote cell survival following DNA damage. Oncogene 2007, 26:3980-3988.
40. Sebastiano V., et al. Oct1 regulates trophoblast development during early mouse embryogenesis. Development 2010, 137:3551-3560.
41. Segil N., Roberts S.B., Heintz N. Mitotic phosphorylation of the Oct-1 homeodomain and regulation of Oct-1 DNA binding activity. Science 1991, 254:1814-1816.
42. Shakya A., Cooksey R., Cox J.E., Wang V., McClain D.A., Tantin D. Oct1 loss of function induces a coordinate metabolic shift that opposes tumorigenicity. Nat. Cell Biol. 2009, 11:320-327.
43. Sharrocks A.D., Yang S.H., Galanis A. Docking domains and substrate-specificity determination for MAP kinases. Trends Biochem. Sci. 2000, 25:448-453.
44. Stunkel W., Kober I., Seifart K.H. A nucleosome positioned in the distal promoter region activates transcription of the human U6 gene. Mol. Cell. Biol. 1997, 17:4397-4405.
45. Sturm R.A., Das G., Herr W. The ubiquitous octamer-binding protein Oct-1 contains a POU domain with a homeo box subdomain. Genes Dev. 1988, 2:1582-1599.
46. Tanoue T., Nishida E. Molecular recognitions in the MAP kinase cascades. Cell. Signal. 2003, 15:455-462.
47. Tantin D., Schild-Poulter C., Wang V., Hache R.J., Sharp P.A. The octamer binding transcription factor Oct-1 is a stress sensor. Cancer Res. 2005, 65:10750-10758.
48. Thornton T.M., Rincon M. Non-classical p38 map kinase functions: cell cycle checkpoints and survival. Int. J. Biol. Sci. 2009, 5:44-51.
49. Tibbles L.A., Woodgett J.R. The stress-activated protein kinase pathways. Cell. Mol. Life Sci. 1999, 55:1230-1254.
50. Torres M. Mitogen-activated protein kinase pathways in redox signaling. Front. Biosci. 2003, 8:d369-d391.
51. Ullman K.S., Flanagan W.M., Edwards C.A., Crabtree G.R. Activation of early gene expression in T lymphocytes by Oct-1 and an inducible protein, OAP40. Science 1991, 254:558-562.
52. Wahl M.C., Will C.L., Luhrmann R. The spliceosome: design principles of a dynamic RNP machine. Cell 2009, 136:701-718.
53. Wang X., Martindale J.L., Liu Y., Holbrook N.J. The cellular response to oxidative stress: influences of mitogen-activated protein kinase signalling pathways on cell survival. Biochem. J. 1998, 333(Pt 2):291-300.
54. Wang V.E., Schmidt T., Chen J., Sharp P.A., Tantin D. Embryonic lethality, decreased erythropoiesis, and defective octamer-dependent promoter activation in Oct-1-deficient mice. Mol. Cell. Biol. 2004, 24:1022-1032.
55. Wang Z., Ge L., Wang M., Carr B.I. Phosphorylation regulates Myc expression via prolonged activation of the mitogen-activated protein kinase pathway. J. Cell. Physiol. 2006, 208:133-140.
56. Willis I.M. RNA polymerase III. Genes, factors and transcriptional specificity. Eur. J. Biochem. 1993, 212:1-11.
57. Yang H.S., Cho M.H., Zakowicz H., Hegamyer G., Sonenberg N., Colburn N.H. A novel function of the MA-3 domains in transformation and translation suppressor Pdcd4 is essential for its binding to eukaryotic translation initiation factor 4A. Mol. Cell. Biol. 2004, 24:3894-3906.
58. Zarubin T., Han J. Activation and signaling of the p38 MAP kinase pathway. Cell Res. 2005, 15:11-18.
59. Zhao H., Jin S., Fan F., Fan W., Tong T., Zhan Q. Activation of the transcription factor Oct-1 in response to DNA damage. Cancer Res. 2000, 60:6276-6280.
60. Zhao X., Pendergrast P.S., Hernandez N. A positioned nucleosome on the human U6 promoter allows recruitment of SNAPc by the Oct-1 POU domain. Mol. Cell 2001, 7:539-549.